Sign in
CompletedNo phase

Muscle Ultrasound Study in Shock Patients

Key facts

Who runs it
University Hospital, Geneva
Where
Switzerland1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
30 people enrolled
Started
13 Oct 2020
Ended
20 Aug 2024
Type of study
Observational
Treatments tested
  • Diaphragm ultrasound (DUS)
  • Peripheral Muscle Ultrasound (PMUS)
  • Airway occlusion pressure (P0.1)
  • Medical Research Council (MRC) sum score
Record updated
9 December 2024

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 19 criteriaShow less

Who can take part

  • adult patients (> 18 years old) admitted to the ICU
  • with a diagnosis of septic shock
  • a SOFA score equal or superior to 8 points, at ICU admission
  • blood lactate concentration above 2 mmol/L, at ICU admission
  • expected to have more than 48h of mechanical ventilation (estimated by the attending physician)
  • expected to stay more than 5 days in the unit (estimated by the attending physician)
  • able to walk prior to ICU admission / walking aids accepted

Who cannot take part

  • diagnosed neuromuscular or central nervous system diseases
  • cancers derived sarcopenia
  • anorexic disorders (protein-energy malnutrition)
  • pregnancy
  • lower limb amputation, fixators or open wounds
  • thoracic fixators or open wounds
  • being transferred from another ICU
  • spinal cord injury
  • diaphragm pacemaker
  • palliative goals of care
  • cachexia
  • intellectual or cognitive impairments, limiting the ability to follow instructions

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Intensive Care Unit (ICU) patients are known to lose muscle mass and function for many reasons, ranging from prolonged immobilization, to the effects of ICU treatments such as mechanical ventilation (MV), to the critical illness itself. Ultrasonography (US) is widely used in the ICU setting and has greatly evolved in the last decades, since it allows the non-invasive assessment of different structures, using radiation-free and user-friendly technology; its application for the assessment or the skeletal muscle is a promising tool and might help detecting muscle changes and thus several dysfunctions during early stages of ICU stay.

Read full original descriptionShow less

By using skeletal muscle ultrasound at both diaphragm and peripheral levels, the overall aim of this study is to improve knowledge in the early detection of muscle dysfunction and weakness , and their relationship with mechanical ventilation weaning and muscle strength, in critically ill patients suffering from septic shock.

The group in the trial

  • Septic Shock

    Treatment: Diaphragm ultrasound (DUS), Peripheral Muscle Ultrasound (PMUS), Airway occlusion pressure (P0.1), and Medical Research Council (MRC) sum score

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Diaphragm Dysfunction and Peripheral Muscle Wasting in Septic Shock Patients: Exploring Their Relationship Over Time Using Ultrasound Technology
Publications
Record updated
9 December 2024